- Report
- May 2024
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- May 2024
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- May 2024
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- November 2023
- 190 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- October 2023
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- October 2023
- 70 Pages
India
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- February 2024
- 131 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- May 2020
- 112 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 80 Pages
Germany
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- October 2023
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- November 2022
- 208 Pages
Asia Pacific
From €3090EUR$3,450USD£2,634GBP
- Report
- October 2021
- 208 Pages
Global
From €3986EUR$4,450USD£3,398GBP
- Report
- March 2024
- 108 Pages
North America
From €3090EUR$3,450USD£2,634GBP
- Report
- January 2024
- 125 Pages
North America
From €3090EUR$3,450USD£2,634GBP
- Report
- January 2024
- 102 Pages
From €3090EUR$3,450USD£2,634GBP
- Report
- January 2024
- 134 Pages
Europe
From €3090EUR$3,450USD£2,634GBP
- Report
- January 2024
- 120 Pages
Middle East, Africa
From €3090EUR$3,450USD£2,634GBP
- Report
- January 2024
- 167 Pages
Asia Pacific
From €3090EUR$3,450USD£2,634GBP
- Report
- September 2023
- 272 Pages
Global
From €3986EUR$4,450USD£3,398GBP

The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less Read more